TWI241915B - A method of preparing a pharmaceutical end formulation using a nanodispersion - Google Patents

A method of preparing a pharmaceutical end formulation using a nanodispersion Download PDF

Info

Publication number
TWI241915B
TWI241915B TW088106257A TW88106257A TWI241915B TW I241915 B TWI241915 B TW I241915B TW 088106257 A TW088106257 A TW 088106257A TW 88106257 A TW88106257 A TW 88106257A TW I241915 B TWI241915 B TW I241915B
Authority
TW
Taiwan
Prior art keywords
nanodispersion
vitamin
ethanol
miglyol
phase
Prior art date
Application number
TW088106257A
Other languages
English (en)
Chinese (zh)
Inventor
Andreas Werner Supersaxo
Hans Georg Weder
Dietmar Hueglin
Joachim Friedrich Roeding
Original Assignee
Ciba Sc Holding Ag
Vesifact Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Sc Holding Ag, Vesifact Ag filed Critical Ciba Sc Holding Ag
Application granted granted Critical
Publication of TWI241915B publication Critical patent/TWI241915B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
TW088106257A 1998-05-11 1999-04-19 A method of preparing a pharmaceutical end formulation using a nanodispersion TWI241915B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98810422 1998-05-11

Publications (1)

Publication Number Publication Date
TWI241915B true TWI241915B (en) 2005-10-21

Family

ID=8236078

Family Applications (1)

Application Number Title Priority Date Filing Date
TW088106257A TWI241915B (en) 1998-05-11 1999-04-19 A method of preparing a pharmaceutical end formulation using a nanodispersion

Country Status (20)

Country Link
US (2) US7081253B2 (cg-RX-API-DMAC10.html)
EP (1) EP0956853B1 (cg-RX-API-DMAC10.html)
JP (1) JP4755742B2 (cg-RX-API-DMAC10.html)
KR (1) KR100622285B1 (cg-RX-API-DMAC10.html)
CN (1) CN1220483C (cg-RX-API-DMAC10.html)
AR (1) AR019274A1 (cg-RX-API-DMAC10.html)
AT (1) ATE312597T1 (cg-RX-API-DMAC10.html)
AU (1) AU767896B2 (cg-RX-API-DMAC10.html)
BR (1) BRPI9902068B8 (cg-RX-API-DMAC10.html)
CZ (1) CZ166999A3 (cg-RX-API-DMAC10.html)
DE (1) DE59912910D1 (cg-RX-API-DMAC10.html)
ES (1) ES2253871T3 (cg-RX-API-DMAC10.html)
HU (1) HUP9901570A2 (cg-RX-API-DMAC10.html)
ID (1) ID22565A (cg-RX-API-DMAC10.html)
MY (1) MY133019A (cg-RX-API-DMAC10.html)
PL (1) PL332934A1 (cg-RX-API-DMAC10.html)
RU (1) RU2224505C2 (cg-RX-API-DMAC10.html)
SG (1) SG71923A1 (cg-RX-API-DMAC10.html)
TW (1) TWI241915B (cg-RX-API-DMAC10.html)
ZA (1) ZA993200B (cg-RX-API-DMAC10.html)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9908309D0 (en) * 1999-04-12 1999-06-02 Phares Pharm Res Nv Lipid aggregate forming compositions and their use
FR2805761B1 (fr) * 2000-03-02 2002-08-30 Mainelab Nanocapsules lipidiques, procede de preparation et utilisation comme medicament
TW586945B (en) * 2001-01-12 2004-05-11 Novartis Ag Lens care product containing dexpanthenol
US20030113366A1 (en) * 2001-12-14 2003-06-19 Macgregor Alexander Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents
RU2200558C1 (ru) * 2002-04-23 2003-03-20 Нестерук Владимир Викторович Лекарственное средство, содержащее финастерид
AT6609U3 (de) * 2003-04-07 2004-04-26 Unipack Ges M B H Abfuell Und Verfahren zum herstellen einer klaren lecithin enthaltenden oralen zubereitung
ITMI20032019A1 (it) * 2003-10-17 2005-04-18 Fidia Farmaceutici Microemulsioni di retinoidi e composizioni farmaceutiche che le contengono
TWI350183B (en) * 2003-12-31 2011-10-11 Ind Tech Res Inst A liposome and a preparation method
PL1768650T3 (pl) * 2004-06-04 2009-01-30 Camurus Ab Ciekłe formulacje depot
US20060198891A1 (en) * 2004-11-29 2006-09-07 Francois Ravenelle Solid formulations of liquid biologically active agents
US20090107495A1 (en) * 2005-07-21 2009-04-30 National Institute For Materials Science Device for inhalation of medicine
US9839667B2 (en) 2005-10-14 2017-12-12 Allergan, Inc. Prevention and treatment of ocular side effects with a cyclosporin
US7745400B2 (en) 2005-10-14 2010-06-29 Gregg Feinerman Prevention and treatment of ocular side effects with a cyclosporin
EP2013016B8 (en) 2006-03-29 2014-10-08 Wayne State University Liposomal nanoparticles and other formulations of fenretinide for use in therapy and drug delivery
JP4840031B2 (ja) 2006-08-31 2011-12-21 ソニー株式会社 ナビゲーション装置、ナビゲーション処理方法及びナビゲーション処理プログラム
GB0623838D0 (en) * 2006-11-29 2007-01-10 Malvern Cosmeceutics Ltd Novel compositions
EP1938801A1 (en) * 2006-12-22 2008-07-02 Biofrontera Bioscience GmbH Nanoemulsion
CL2008000037A1 (es) * 2007-01-16 2008-10-10 Bayer Consumer Care Ag Solucion coloidal que comprende al menos un ingrediente activo, al menos una molecula formadora de membrana y al menos un componente espumante; procedimiento para fabricar la solucion coloidal; y su uso para tratar trastornos dermatologicos.
US8703204B2 (en) 2007-05-03 2014-04-22 Bend Research, Inc. Nanoparticles comprising a cholesteryl ester transfer protein inhibitor and anon-ionizable polymer
WO2008135828A2 (en) 2007-05-03 2008-11-13 Pfizer Products Inc. Nanoparticles comprising a drug, ethylcellulose, and a bile salt
EP2162120B1 (en) 2007-06-04 2016-05-04 Bend Research, Inc Nanoparticles comprising a non-ionizable cellulosic polymer and an amphiphilic non-ionizable block copolymer
WO2008149230A2 (en) 2007-06-04 2008-12-11 Pfizer Products Inc. Nanoparticles comprising drug, a non-ionizable cellulosic polymer and tocopheryl polyethylene glycol succinate
EP2240162A4 (en) 2007-12-06 2013-10-09 Bend Res Inc NANOTE PARTICLES WITH A NON-IONIZABLE POLYMER AND AN AMIN-FUNCTIONALIZED METHACRYLATE COPOLYMER
WO2009073215A1 (en) 2007-12-06 2009-06-11 Bend Research, Inc. Pharmaceutical compositions comprising nanoparticles and a resuspending material
CN100536826C (zh) * 2007-12-28 2009-09-09 清华大学 一种绵羊油纳米乳液及其制备方法和应用
US20110033545A1 (en) * 2009-08-06 2011-02-10 Absize, Inc. Topical pharmaceutical preparations having both a nanoparticle solution and a nanoparticle suspension and methods for the treatment of acute and chronic pain therewith
FR2949063B1 (fr) * 2009-08-11 2011-09-30 Pf Medicament Composition pharmaceutique comprenant un ester de dha destinee a etre administree par voie parenterale
DE202010004750U1 (de) 2010-04-09 2011-10-11 Biofrontera Bioscience Gmbh Pharmazeutische oder/und kosmetische Zusammensetzung zur Behandlung der Haut
CN102277748A (zh) * 2010-06-12 2011-12-14 罗莱家纺股份有限公司 纳米维生素微胶囊整理剂的使用方法
KR101494594B1 (ko) 2011-08-30 2015-02-23 주식회사 종근당 약리학적 활성물질의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물
KR101586789B1 (ko) 2012-12-28 2016-01-19 주식회사 종근당 양이온성 약리학적 활성물질의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물
KR101586790B1 (ko) 2012-12-28 2016-01-19 주식회사 종근당 음이온성 약리학적 활성물질의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물
KR101586791B1 (ko) 2012-12-28 2016-01-19 주식회사 종근당 GnRH 유도체의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물
EP3583954A1 (en) * 2018-06-19 2019-12-25 neubourg skin care GmbH Nanodispersions of birch bark extract, electrospun fibers containing such nanodispersions and their use for the treatment of wounds
US12171729B2 (en) 2019-11-25 2024-12-24 The Johns Hopkins University Formulations of terameprocol and temozolomide and their use in stimulation of humoral immunity in tumors
CN111388744B (zh) * 2020-01-15 2021-05-18 华中科技大学 一种凝胶贮库及其制法与制备术后止血制剂的应用
BR112022015829A2 (pt) * 2020-02-11 2022-10-25 Advent Therapeutics Inc Composições de palmitato de vitamina a, processos para sua preparação, usos e métodos que as compreendem
WO2021233967A1 (en) * 2020-05-20 2021-11-25 Intervet International B.V. Injectable pharmaceutical compositions and uses thereof
WO2021247542A2 (en) * 2020-06-01 2021-12-09 Advent Therapeutics, Inc. Pharmaceutical compositions comprising insoluble active ingredients
KR102628523B1 (ko) 2020-06-30 2024-01-24 주식회사 종근당 GnRH 유도체를 포함하는 주사용 조성물
WO2024165166A1 (en) 2023-02-10 2024-08-15 Tetra Pharm Technologies A cannabinoid-based o/w emulsification system for oral administration targeting endocannabinoid receptors
WO2024208434A1 (en) 2023-04-06 2024-10-10 Biofrontera Bioscience Gmbh Pressurized nanoemulsion
WO2024208433A1 (en) 2023-04-06 2024-10-10 Biofrontera Bioscience Gmbh Nanoemulsion without propylene glycol

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3150990A1 (de) 1981-12-23 1983-06-30 A. Nattermann & Cie GmbH, 5000 Köln Neue pflanzenschutzmittelsuspensionskonzentrate
US4675193A (en) * 1983-10-31 1987-06-23 Borden, Inc. Cheese-flavored substance and method of producing same
US4816247A (en) * 1985-09-11 1989-03-28 American Cyanamid Company Emulsion compositions for administration of sparingly water soluble ionizable hydrophobic drugs
CA1321144C (en) 1986-08-07 1993-08-10 Henrich H. Paradies Pharmaceutical preparations
DE3852409T2 (de) 1987-01-27 1995-04-20 Vestar Inc Aus Phospholipiden bestehende Darreichungsform für wasserunlösliche Wirksubstanzen.
EP0349150B1 (en) * 1988-06-20 1994-08-17 Shiseido Company Limited Transparent compostition
US5338761A (en) * 1988-09-29 1994-08-16 Shiseido Company Ltd. Emulsified composition
FR2648462B1 (fr) * 1989-06-15 1994-01-28 Oreal Procede pour ameliorer l'efficacite therapeutique de corticosteroides liposolubles et composition pour la mise en oeuvre de ce procede
CH677886A5 (cg-RX-API-DMAC10.html) * 1989-06-26 1991-07-15 Hans Georg Prof Dr Weder
JP2785981B2 (ja) * 1989-11-20 1998-08-13 株式会社資生堂 乳化組成物
US5688761A (en) * 1991-04-19 1997-11-18 Lds Technologies, Inc. Convertible microemulsion formulations
DE69229779T2 (de) * 1991-04-19 1999-12-23 Lds Technologies, Inc. Konvertierbare mikroemulsionsverbindungen
DK0597007T3 (da) * 1991-07-26 1996-11-18 Smithkline Beecham Corp V/O mikroemulsioner
US5260065A (en) 1991-09-17 1993-11-09 Micro Vesicular Systems, Inc. Blended lipid vesicles
IL101007A (en) * 1992-02-18 1997-08-14 Pharmos Ltd Dry stable compositions prepared by lyophilization
IL101387A (en) 1992-03-26 1999-11-30 Pharmos Ltd Emulsion with enhanced topical and/or transdermal systemic effect utilizing submicron oil droplets
US5576016A (en) * 1993-05-18 1996-11-19 Pharmos Corporation Solid fat nanoemulsions as drug delivery vehicles
CH685674A5 (de) 1993-12-19 1995-09-15 Marigen Sa Ultramikroemulsionen aus spontan dispergierbaren Konzentraten mit pharmakologisch wirksamen Estern von Apocarotinolen.
ES2094688B1 (es) * 1994-08-08 1997-08-01 Cusi Lab Manoemulsion del tipo de aceite en agua, util como vehiculo oftalmico y procedimiento para su preparacion.
MY129435A (en) * 1994-10-26 2007-04-30 Novartis Ag Pharmaceutical microemulsion preconcentrates
EP0711556A1 (de) * 1994-11-09 1996-05-15 Ciba-Geigy Ag Intravenöse Lösungen für ein Staurosporinderivat
EP0733372A3 (de) * 1995-03-21 1998-05-20 Ciba-Geigy Ag Pharmazeutische Formulierungsgrundlage für Nanosuspensionen
WO1996037192A1 (en) * 1995-05-26 1996-11-28 Vesifact Ag Pharmaceutical and cosmetic compositions containing sphingo- and glycolipids
DE19522693A1 (de) 1995-06-22 1997-01-02 Dianorm G Maierhofer Gmbh Zusammensetzung zur Herstellung feindisperser Systeme und Verfahren zu ihrer Herstellung
JP3508314B2 (ja) * 1995-08-18 2004-03-22 大正製薬株式会社 ビタミンcを配合した液剤
WO1997021428A1 (de) * 1995-12-12 1997-06-19 Vesifact Ag Cortisolspray zur topischen verabreichung
US6245349B1 (en) * 1996-02-23 2001-06-12 éLAN CORPORATION PLC Drug delivery compositions suitable for intravenous injection
DE59710082D1 (de) * 1996-12-13 2003-06-18 Vesifact Ag Baar Kosmetische Präparate in Form einer Nanodispersion
US6028067A (en) * 1997-12-05 2000-02-22 Chong Kun Dang Corp. Cyclosporin-containing microemulsion preconcentrate composition

Also Published As

Publication number Publication date
AR019274A1 (es) 2002-02-13
US20060292191A1 (en) 2006-12-28
SG71923A1 (en) 2000-04-18
MY133019A (en) 2007-10-31
KR100622285B1 (ko) 2006-09-11
PL332934A1 (en) 1999-11-22
AU2805099A (en) 1999-11-18
BR9902068B1 (pt) 2014-10-29
HU9901570D0 (en) 1999-07-28
EP0956853A2 (de) 1999-11-17
CN1235017A (zh) 1999-11-17
JP4755742B2 (ja) 2011-08-24
EP0956853A3 (de) 2000-01-05
BRPI9902068B8 (pt) 2021-05-25
US7871642B2 (en) 2011-01-18
RU2224505C2 (ru) 2004-02-27
ES2253871T3 (es) 2006-06-01
EP0956853B1 (de) 2005-12-14
US20030190347A1 (en) 2003-10-09
CN1220483C (zh) 2005-09-28
US7081253B2 (en) 2006-07-25
ZA993200B (en) 1999-11-11
AU767896B2 (en) 2003-11-27
BR9902068A (pt) 2000-06-06
HUP9901570A2 (hu) 2001-06-28
DE59912910D1 (de) 2006-01-19
CZ166999A3 (cs) 1999-11-17
JPH11335266A (ja) 1999-12-07
ID22565A (id) 1999-11-11
ATE312597T1 (de) 2005-12-15
KR19990088156A (ko) 1999-12-27

Similar Documents

Publication Publication Date Title
JP4755742B2 (ja) 医薬最終処方物におけるナノディスパージョンの使用
Tanigawa et al. Treatment of cystic hygroma and lymphangioma with the use of bleomycin fat emulsion
KR100369258B1 (ko) 옥시에틸렌화 또는 비-옥시에틸렌화 소르비탄지방에스테르 기재 나노에멀젼, 및 화장, 피부학 및/또는안과학 분야에서의 그의 용도
US9572770B2 (en) Stable topical composition and a process for producing a stable topical composition
RU2491917C2 (ru) Наноэмульсия
TWI290052B (en) Emulsion vehicle for poorly soluble drugs
TW505526B (en) Emulsion suitable for administering a poorly water-soluble photosensitizing compound
CA2193497C (en) Controlled release aqueous emulsion
US6479540B1 (en) Compositions of tocol-soluble therapeutics
JP3545299B2 (ja) アルキルエーテルクエン酸エステルベースのナノエマルジョン、及び化粧料、皮膚科学、薬学及び/又は眼科学分野におけるその使用
JPS63501278A (ja) 水性相中に分散した脂質小球体を容易にそして高い安定性およびカプセル化度をもつように形成する方法
JPH02502822A (ja) 非結晶性ミノキシジル組成物およびその投与方法
PT981328E (pt) Composição formadora de uma emulsão para um composto taxóide.
JPH07505368A (ja) 超微小油球体を用いての局部用及び経皮用投与システム
JP2006008700A (ja) 超微小油球体を用いての局部用及び経皮用投与システム
Sarkar Pharmaceutical emulsions: a drug developer's toolbag
JP2002322016A (ja) 水−分散性ポリマーで安定化した親油性活性成分のナノスフェアの懸濁物
JPH02203A (ja) 薬物担体
WO1997021428A1 (de) Cortisolspray zur topischen verabreichung
EP1256337A1 (de) Verfahren und Zusammensetzungen zum Aufbringen eines Wirkstoffs auf ein Substrat
TWI911987B (zh) 含有傳明酸與維a酸的複方組合物
JP4521899B2 (ja) クロタミトン含有皮膚外用液剤
JPH1147580A (ja) リポソーム分散液の製造方法
MXPA99004334A (es) Uso de nanodispersiones en formulaciones farmaceuticas finales
JPH04145020A (ja) ニトログリセリンのリポゾーム及びそれを含む製剤

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees